Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

Summary of Outstanding Potentially Dilutive Common Stock Equivalents have been Excluded from the Calculation of Diluted Net Loss Per Share

The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods presented due to their antidilutive effect:

	Three Months Ended
	March 31,
	2025		2024
Warrants to purchase common stock		699,710		3,503
Common stock options issued and outstanding		8,868		3,199
Restricted stock units issued and outstanding		79,415		—
Series A Preferred Stock		288,588		—
Total		1,076,581		6,702